GLP-1 and Skin Health: Collagen, Wound Healing, and Dermatological Effects

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Glucagon-like peptide-1 (GLP-1) receptor agonists, primarily recognized for their roles in metabolic regulation and weight management, are increasi...

# GLP-1 and Skin Health: Collagen, Wound Healing, and Dermatological Effects

Glucagon-like peptide-1 (GLP-1) receptor agonists, primarily recognized for their roles in metabolic regulation and weight management, are increasingly being investigated for their broader systemic effects, including potential impacts on skin health. This extends to areas such as collagen synthesis, wound healing, and various dermatological manifestations. Understanding these connections is vital for a comprehensive view of GLP-1 therapy.

Impact on Collagen and Skin Elasticity

Weight loss, a significant outcome of GLP-1 agonist therapy, can inherently influence skin appearance. Rapid or substantial weight reduction can lead to decreased subcutaneous fat, which may result in reduced skin turgor and elasticity, potentially exacerbating the appearance of wrinkles or sagging skin [1]. This is not a direct effect of GLP-1 on collagen but rather a consequence of the underlying fat loss.

However, emerging research is exploring more direct interactions. While GLP-1 receptor agonists do not directly stimulate collagen production in the same way as some cosmetic treatments, their influence on metabolic pathways, inflammation, and cellular health could indirectly affect dermal integrity. Preclinical studies are investigating the impact of GLP-1 receptor agonist-induced fat loss on collagen synthesis and skin elasticity, with a focus on dermal health and collagen turnover [2]. The structural proteins like collagen and elastin are crucial for maintaining skin firmness, and any systemic factor influencing their health could have dermatological implications.

GLP-1 and Wound Healing

The role of GLP-1 agonists in wound healing presents a more complex picture, with both potential benefits and considerations:

Improved Venous Ulcer Healing: Some studies suggest that the use of GLP-1 receptor agonists is associated with improved healing of venous ulcers. Patients treated with GLP-1 RAs were found to be less likely to experience delayed healing [3]. This could be attributed to the anti-inflammatory effects of GLP-1s and their positive impact on metabolic control, which are critical for chronic wound management.

Promotion of Angiogenesis and Keratinocyte Function: GLP-1 agonists may promote wound healing through various mechanisms, including enhanced angiogenesis (formation of new blood vessels) and improved keratinocyte function, both essential processes for tissue repair [4]. For instance, liraglutide, another GLP-1 analogue, has been shown to facilitate wound healing by activating the PI3K/Akt pathway in keratinocytes [5].

Delayed Surgical Wound Healing: Conversely, there are reports linking GLP-1 receptor agonist use to delayed surgical wound healing, particularly following procedures like panniculectomy [6]. This might be due to altered tissue metabolism or other systemic effects that impact the intricate process of surgical recovery. Some case reports highlight risks of delayed wound healing, fat necrosis, and tissue fragility in patients undergoing breast surgery while on GLP-1 receptor agonists [7].

These contrasting findings underscore the need for careful patient selection and management, especially in surgical contexts.

Dermatological Effects and Side Effects

GLP-1 agonists can also have various dermatological effects, some of which are adverse reactions:

Injection-Site Reactions: The most common dermatological adverse effects are injection-site reactions, including erythema (redness), swelling, itching, and nodular formations [8]. These are generally localized and transient.

Hair Thinning and Volume Loss: Patients on GLP-1 agonists, particularly those experiencing significant weight loss, may report hair thinning or loss. This is often multifactorial, potentially related to rapid weight loss itself, nutritional deficiencies, or hormonal shifts. Facial volume loss is also a reported concern, as the reduction in subcutaneous fat can alter facial contours [9].

Impact on Inflammatory Skin Diseases: GLP-1 receptor agonists may impact inflammatory skin diseases like psoriasis and hidradenitis suppurativa through their immune-modulating and anti-inflammatory properties [10]. The anti-inflammatory effects of GLP-1 agonists have been attributed to improvements in certain skin conditions [11].

  • Excessive Sweating: Some individuals may experience increased sweating as a side effect [9].

    • Clinical Considerations

    For clinicians, it is important to counsel patients on GLP-1 therapy about potential skin changes. While the metabolic benefits are substantial, managing dermatological concerns requires a nuanced approach. For patients undergoing surgery, a discussion about pausing GLP-1 agonists pre-operatively might be warranted, given the potential for delayed wound healing.

    Further research, particularly large-scale clinical trials, is needed to fully characterize the dermatological profile of GLP-1 agonists and to develop strategies for mitigating adverse effects while maximizing therapeutic benefits.

    References

    [1] GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions - https://www.preprints.org/frontend/manuscript/b0714be486d8e9fe95dfcbc85df1634c/download_pub

    [2] Investigating the impact of GLP-1 receptor agonist-induced fat loss on collagen synthesis and skin elasticity - https://www.researchgate.net/profile/Donna-Pham/publication/390265522_Investigating_the_Impact_of_GLP-1_Receptor_Agonist-Induced_Fat_Loss_on_Collagen_Synthesis_and_Skin_Elasticity/links/67e6c6a59b1c6c487760284b/Investigating-the-Impact-of-GLP-1-Receptor-Agonist-Induced_Fat_Loss_on_Collagen_Synthesis_and_Skin_Elasticity.pdf

    [3] GLP-1 receptor agonist use is associated with venous ulcer healing ... - https://www.sciencedirect.com/science/article/abs/pii/S089050962600186X

    [4] The Emerging Role of GLP-1 Agonists in Burn Care - PubMed - https://pubmed.ncbi.nlm.nih.gov/39405180/

    [5] Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes - https://www.sciencedirect.com/science/article/pii/S0168822718312816

    [6] GLP-1 Receptor Agonist Use Linked to Delayed Surgical Wound ... - https://www.gastroenterologyadvisor.com/news/glp-1-receptor-agonist-use-linked-to-delayed-surgical-wound-healing/

    [7] GLP-1 agonists in plastic surgery: impact on aesthetic outcomes—two case reports - https://link.springer.com/article/10.1007/s00266-025-04703-4

    [8] A Closer Look at the Dermatological Profile of GLP-1 Agonists - https://pmc.ncbi.nlm.nih.gov/articles/PMC12110338/

    [9] How can GLP-1 drugs affect my skin, hair, and nails? - https://www.aad.org/public/everyday-care/skin-care-secrets/prevent-skin-problems/glp1-drugs-and-side-effects

    [10] GLP-1RA & Inflammatory Skin Diseases - https://www.usdermatologypartners.com/blog/glp-1ra-inflammatory-skin-diseases/

    [11] The use of GLP-1 agonists in the management of cutaneous disease - https://pmc.ncbi.nlm.nih.gov/articles/PMC11386968/